We are live on
!
Find out more
SFU
Stonehage Fleming (UK) Portfolio holdings
AUM
$220M
1-Year Est. Return
0.72%
This Fund
S&P 500
This Quarter
Est. Return
+10.8%
1 Year Est. Return
+0.72%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$247M
AUM Growth
–
Cap. Flow
+$236M
Cap. Flow
% of AUM
95.8%
Top 10 Holdings %
Top 10 Hldgs %
26.64%
Holding
266
New
265
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$10.7M |
| 2 |
Cemex
CX
|
+$10.3M |
| 3 |
AbbVie
ABBV
|
+$5.83M |
| 4 |
Intel
INTC
|
+$5.8M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$5.68M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.39% |
| 2 | Industrials | 13.79% |
| 3 | Healthcare | 13.67% |
| 4 | Materials | 10.07% |
| 5 | Consumer Discretionary | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.54T
| $11.4M | 4.61% |
+567,476
| New | +$10.7M |
|
|
2
Cemex
CX
$17.1B
| $11.1M | 4.52% |
+1,102,254
| New | +$10.3M |
|
3
Nu Skin
NUS
$252M
| $6.42M | 2.6% |
+46,400
| New | +$5.46M |
|
|
4
AbbVie
ABBV
$443B
| $6.27M | 2.54% |
+118,700
| New | +$5.83M |
|
|
5
Intel
INTC
$455B
| $6.23M | 2.52% |
+239,974
| New | +$5.8M |
|
|
MXIM
6
DELISTED
Maxim Integrated Products
MXIM
| $5.48M | 2.22% |
+196,400
| New | +$5.68M |
|
|
SPLS
7
DELISTED
Staples Inc
SPLS
| $5.39M | 2.18% |
+339,000
| New | +$5.29M |
|
8
Deluxe
DLX
$1.18B
| $5.1M | 2.07% |
+97,799
| New | +$4.67M |
|
9
Western Union
WU
$1.98B
| $4.24M | 1.72% |
+245,650
| New | +$4.3M |
|
10
Microsoft
MSFT
$3.45T
| $4.12M | 1.67% |
+110,108
| New | +$4M |
|
11
iShares Silver Trust
SLV
$28B
| $3.95M | 1.6% |
+211,088
| New | +$4.23M |
|
12
Dover
DOV
$27.6B
| $3.88M | 1.57% |
+59,973
| New | +$3.67M |
|
|
DNY
13
DELISTED
DONNELLEY R R & SONS CO
DNY
| $3.67M | 1.49% |
+181,100
| New | +$3.67M |
|
14
Pitney Bowes
PBI
$2.4B
| $3.64M | 1.47% |
+156,200
| New | +$3.36M |
|
15
Gilead Sciences
GILD
$162B
| $3.58M | 1.45% |
+47,696
| New | +$3.32M |
|
16
McKesson
MCK
$100B
| $3.52M | 1.42% |
+21,790
| New | +$3.35M |
|
17
Emerson Electric
EMR
$83.9B
| $3.49M | 1.41% |
+49,700
| New | +$3.32M |
|
|
PPLI
18
People Inc
PPLI
$3.09B
| $3.43M | 1.39% |
+278,987
| New | +$2.88M |
|
19
Medtronic
MDT
$109B
| $3.31M | 1.34% |
+57,760
| New | +$3.28M |
|
20
Bread Financial
BFH
$4.37B
| $3.31M | 1.34% |
+15,788
| New | +$3.01M |
|
21
GE Aerospace
GE
$374B
| $3.22M | 1.3% |
+23,936
| New | +$3.01M |
|
|
VIAB
22
DELISTED
Viacom Inc. Class B
VIAB
| $3.2M | 1.29% |
+36,600
| New | +$3.02M |
|
23
Verizon
VZ
$195B
| $3.15M | 1.27% |
+64,020
| New | +$3.15M |
|
24
SPDR Gold Trust
GLD
$131B
| $3M | 1.21% |
+25,800
| New | +$3.17M |
|
25
NetEase
NTES
$85.3B
| $2.88M | 1.17% |
+183,000
| New | +$2.57M |
|
Similar funds
AHS
KM
TC
IA
BL
QA
THP
SGH
Stonehage Fleming (UK)'s Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for Stonehage Fleming (UK), which disclosed 266 positions worth $247M. Its ten largest holdings account for 27% of the portfolio.
Its largest position is Apple: 567,476 shares worth $11.4M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, followed by Industrials and Healthcare.
- Stonehage Fleming (UK)'s largest Q4 2013 buy was Apple: 567,476 shares worth $11.4M.
- Stonehage Fleming (UK)'s ten largest holdings make up 27% of its $247M portfolio in Q4 2013.
- Stonehage Fleming (UK) disclosed 266 positions in Q4 2013, its first 13F filing on record.
Based on Stonehage Fleming (UK)'s 13F filing for Q4 2013, filed 11 Oct 2019.